BLIS Technologies Limited (NZ:BLT)
:BLT
Want to see NZ:BLT full AI Analyst Report?
BLT Stock Chart & Stats
0.02
0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range0.01 - 0.02
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
$20.47M
Enterprise Value17.99M
Total Cash (Recent Filing)$8.82M
Total Debt (Recent Filing)$526.00K
Price to Earnings (P/E)12.2
Beta0.34
Next Earnings
May 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,279,301,600
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.53
Price to Book (P/B)1.45
Price to Sales (P/S)1.55
P/FCF Ratio13.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BLT FAQ
What was BLIS Technologies Limited’s price range in the past 12 months?
BLIS Technologies Limited lowest stock price was 0.01 and its highest was 0.02 in the past 12 months.
What is BLIS Technologies Limited’s market cap?
BLIS Technologies Limited’s market cap is $20.47M.
When is BLIS Technologies Limited’s upcoming earnings report date?
BLIS Technologies Limited’s upcoming earnings report date is May 21, 2026 which is in 21 days.
How were BLIS Technologies Limited’s earnings last quarter?
BLIS Technologies Limited released its earnings results on Nov 12, 2025. The company reported 0 earnings per share for the quarter, the consensus estimate of N/A by 0.
Is BLIS Technologies Limited overvalued?
According to Wall Street analysts BLIS Technologies Limited’s price is currently Undervalued.
Does BLIS Technologies Limited pay dividends?
BLIS Technologies Limited does not currently pay dividends.
What is BLIS Technologies Limited’s EPS estimate?
BLIS Technologies Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BLIS Technologies Limited have?
BLIS Technologies Limited has 1,279,301,600 shares outstanding.
What happened to BLIS Technologies Limited’s price movement after its last earnings report?
BLIS Technologies Limited reported an EPS of 0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BLIS Technologies Limited?
Currently, no hedge funds are holding shares in NZ:BLT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BLIS Technologies Limited
BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity. The company markets two strains of probiotic bacteria, which include BLIS K12, a probiotic supplement to support ear, nose, and throat health of young children, as well as for improving immunity and bad breath; BLIS M18, an oral probiotic to support teeth, gums, and dental health; and BLIS Q24, a probiotic supplement to balance and restore the skin microbiome, restoring the health, clarity, and radiance. It has operations in New Zealand, Asia Pacific, Europe, the Middle East, Africa, and North America. The company was incorporated in 2000 and is based in Dunedin, New Zealand.
Vital Limited
―
Promisia Healthcare Limited
―
Third Age Health Services Limited
―
Radius Residential Care Ltd
―
Rua Bioscience Ltd.
―